For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a study in the July Journal of the American Society of Nephrology (JASN).
“We demonstrated a robust association between sirolimus and diabetes after transplantation in a large group of kidney transplant recipients in the United States,” […]











May 24th, 2008 at 7:41 am
[…] Posted by as Uncategorized For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a study in the July Journal of the American Society of Nephrology (JASN). …article continues at unknown brought to you by diabetes.medtrials.info and medtrials.info […]